JP2004504323A5 - - Google Patents

Download PDF

Info

Publication number
JP2004504323A5
JP2004504323A5 JP2002512186A JP2002512186A JP2004504323A5 JP 2004504323 A5 JP2004504323 A5 JP 2004504323A5 JP 2002512186 A JP2002512186 A JP 2002512186A JP 2002512186 A JP2002512186 A JP 2002512186A JP 2004504323 A5 JP2004504323 A5 JP 2004504323A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
acid addition
free base
addition salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002512186A
Other languages
English (en)
Japanese (ja)
Other versions
JP3939246B2 (ja
JP2004504323A (ja
Filing date
Publication date
Priority claimed from GBGB0017508.3A external-priority patent/GB0017508D0/en
Application filed filed Critical
Publication of JP2004504323A publication Critical patent/JP2004504323A/ja
Publication of JP2004504323A5 publication Critical patent/JP2004504323A5/ja
Application granted granted Critical
Publication of JP3939246B2 publication Critical patent/JP3939246B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002512186A 2000-07-17 2001-07-16 インドロキナゾリノン類 Expired - Fee Related JP3939246B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0017508.3A GB0017508D0 (en) 2000-07-17 2000-07-17 Antimicrobials
PCT/EP2001/008192 WO2002006284A1 (en) 2000-07-17 2001-07-16 Indoloquinazolinones

Publications (3)

Publication Number Publication Date
JP2004504323A JP2004504323A (ja) 2004-02-12
JP2004504323A5 true JP2004504323A5 (enExample) 2005-02-03
JP3939246B2 JP3939246B2 (ja) 2007-07-04

Family

ID=9895801

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002512186A Expired - Fee Related JP3939246B2 (ja) 2000-07-17 2001-07-16 インドロキナゾリノン類

Country Status (18)

Country Link
US (1) US6964960B2 (enExample)
EP (1) EP1303517B1 (enExample)
JP (1) JP3939246B2 (enExample)
CN (1) CN1183136C (enExample)
AR (1) AR031379A1 (enExample)
AT (1) ATE262530T1 (enExample)
AU (1) AU2001279754A1 (enExample)
BR (1) BR0112521A (enExample)
CA (1) CA2415683C (enExample)
DE (1) DE60102473T2 (enExample)
DK (1) DK1303517T3 (enExample)
ES (1) ES2218439T3 (enExample)
GB (1) GB0017508D0 (enExample)
MY (1) MY133969A (enExample)
PE (1) PE20020210A1 (enExample)
PT (1) PT1303517E (enExample)
TR (1) TR200401026T4 (enExample)
WO (1) WO2002006284A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956035B2 (en) 2001-08-31 2005-10-18 Inotek Pharmaceuticals Corporation Isoquinoline derivatives and methods of use thereof
KR20050118169A (ko) 2003-02-28 2005-12-15 이노텍 파마슈티컬스 코포레이션 사환식 벤즈아미드 유도체 및 이것의 사용 방법
JP2008531562A (ja) 2005-02-25 2008-08-14 イノテック ファーマシューティカルズ コーポレイション 四環アミノ化合物および四環カルボキサミド化合物およびこれらの使用法
RU2008110955A (ru) 2005-08-24 2009-09-27 Инотек Фармасьютикалз Корпорейшн (Us) Инденоизохинолиноновые аналоги и способы их применения
MX2008016339A (es) 2006-06-20 2009-01-16 Abbott Lab Pirazoloquinazolinonas en la forma de inhibidores parp.
GB0615809D0 (en) * 2006-08-09 2006-09-20 Istituto Di Ricerche D Biolog Therapeutic compounds
GB0701273D0 (en) * 2007-01-24 2007-02-28 Angeletti P Ist Richerche Bio New compounds
KR20090115879A (ko) 2007-02-28 2009-11-09 이노텍 파마슈티컬스 코포레이션 인데노이소퀴놀리논 유사체와 이의 이용 방법
NZ580982A (en) 2007-05-08 2012-05-25 Schering Corp Methods of treatment using intravenous formulations comprising temozolomide
KR20140036312A (ko) * 2011-07-13 2014-03-25 산텐 세이야꾸 가부시키가이샤 Parp 저해 활성을 갖는 신규 화합물
CN102766144B (zh) * 2012-07-10 2014-04-23 浙江大学 一种吲哚并[1,2-c]喹唑啉化合物的制备方法
ES2879434T3 (es) 2015-07-23 2021-11-22 Inst Curie Uso de una combinación de molécula Dbait e inhibidores de PARP para tratamiento del cáncer
GB201519573D0 (en) 2015-11-05 2015-12-23 King S College London Combination
WO2018162439A1 (en) 2017-03-08 2018-09-13 Onxeo New predictive biomarker for the sensitivity to a treatment of cancer with a dbait molecule
KR20200130856A (ko) 2018-03-13 2020-11-20 옹쎄오 암 치료에서 획득한 내성에 대한 디베이트 분자
US20220073531A1 (en) * 2018-11-30 2022-03-10 Merck Patent Gmbh Compounds for electronic devices
EP3938367A1 (de) * 2019-03-12 2022-01-19 Merck Patent GmbH Materialien für organische elektrolumineszenzvorrichtungen
CN110357892B (zh) * 2019-07-10 2022-06-07 云南大学 四氢嘧啶并[1,2-a]吲哚衍生物及其合成方法与应用
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
CN114195789B (zh) * 2021-12-15 2022-09-09 广东海洋大学 一种无金属参与的多环吲哚衍生物的制备方法
CN121398822A (zh) 2023-06-21 2026-01-23 四方生物科学有限公司 用于在治疗hr功能正常的癌症的方法中的用途的包含脱氧胞苷衍生物和parp抑制剂的组合

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3635966A (en) 1969-10-22 1972-01-18 Robins Co Inc A H 6-substituted-indolo(1 2-c)quinazolines
DE2237372C3 (de) 1972-07-29 1981-07-09 Basf Ag, 6700 Ludwigshafen Heterocyclische Farbstoffe, ihre Herstellung und ihre Verwendung
US5441955A (en) 1993-11-19 1995-08-15 Pathogenesis Corporation Indolo[2,1-biquinazoline-6,12-dione antibacterial compounds and methods of use thereof
GB9404485D0 (en) 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues

Similar Documents

Publication Publication Date Title
CA2415683A1 (en) Indoloquinazolinones
JP2009542613A5 (enExample)
JP2007501809A5 (enExample)
CA2485641A1 (en) Novel condensed imidazole derivatives
JP2005500988A5 (enExample)
JP2005053931A5 (enExample)
JP2005502658A5 (enExample)
PL377112A1 (pl) Sposoby wytwarzania związków pirolotriazynowych użytecznych jako inhibitory kinazy
IL217445A0 (en) Process for preparing benzazepine compounds or salts thereof
WO2000061783A3 (en) Process for preparing inhibitors of nucleoside metabolism
JP2002513793A5 (enExample)
JP2001510843A5 (enExample)
JP2004532240A5 (enExample)
EP2308828A3 (en) CaSR antagonist
JP2003503449A5 (enExample)
CA2527496A1 (en) 4-substituted derivatives of pyrazolo [3,4-d] pyrimidine and pyrrolo [2,3-d] pyrimidine and uses thereof
JP2004529953A5 (enExample)
JP2002506864A5 (enExample)
JP2006515600A5 (enExample)
JP2005514332A5 (enExample)
JP2004525178A5 (enExample)
JP2005516898A5 (enExample)
JP2006518765A5 (enExample)
JP2006514956A5 (enExample)
JP2004538278A5 (enExample)